Gyan Bhanot, PhD
Professor of Molecular Biology and Biochemistry; and Department of Physics
School of Arts and Sciences, Rutgers University
Research profile

Dr. Bhanot's current research interests are is in the area of Translational Medicine and Evolutionary Biology, particularly working on developing methods to improve chemotherapy outcome, optimize immune checkpoint therapy, and understand the role of the ribosome in evolution.

Chang S. Chan, PhD
Associate Professor of Medicine
Robert Wood Johnson Medical School
Associate Director
Center for Systems and Computational Biology
Research profile

Dr. Chan’s lab is interested in understanding the role of p53 in cancer, and focuses on cancer genomics, cancer evolution and resistance to therapy, and gene regulation.

Subhajyoti De, PhD
Assistant Professor of Pathology and Laboratory Medicine
Robert Wood Johnson Medical School
Lab website

Dr. De’s lab develops and employs computational genomics tools to understand the biology of cancer and apply that knowledge to improve early detection, stratification, and therapeutic opportunities for patients. The interests of the lab include single molecule sequencing, evolutionary dynamics of tumor, genomic instability, and non-coding mutations in cancer. 

David J. Foran, PhD
Chief Informatics Officer and
Executive Director of Biomedical Informatics, Rutgers Cancer Institute of New Jersey
Research profile

Dr. Foran's lab designs, develops, and implements new approaches in computational imaging, statistical pattern recognition, and computer-based diagnostics for resolving challenging problems in oncology / pathology / radiology.

Shridar Ganesan, MD, PhD
Associate Director for Translational Science and Chief, Molecular Oncology,
Rutgers Cancer Institute of New Jersey
Research profile

Dr. Ganesan’s lab studies DNA repair mechanisms and chromatin biology, the role of BRCA1 and 53BP1 in DNA repair, tumorigenesis and chemosensitivity, and genomic classification of human cancer.

Michael L. Gatza, PhD
Assistant Professor of Radiation Oncology
Robert Wood Johnson Medical School
Lab website

Dr. Gatza’s lab leverages cancer genomics and bioinformatics with experimental molecular biology and genetics to identify and elucidate mechanisms of oncogenic signaling and cancer genesis as a means to further understand breast and ovarian tumor biology and to develop personalized cancer therapies.

Daniel Herranz Benito, PharmD, PhD
Assistant Professor of Pharmacology
Robert Wood Johnson Medical School
Lab website

Dr. Herranz’s lab is is focused on  discovering and defining how oncogenic and tumor suppressor enhancers impact tumorigenesis in hematological and solid tumors. The lab also works on dissecting the interplay between cancer cell-specific metabolic rewiring and epigenetics in T-cell Acute Lymphoblastic Leukemia (T-ALL).

Hossein Khiabanian, PhD
Assistant Professor of Pathology
Division of Medical Informatics
Robert Wood Johnson Medical School
Lab website

Dr. Khiabanian’s lab develops mathematical methods and employs high-throughput genomics techniques to understand the underlying genetics of human malignancies, especially to study the evolution of clonal expansions in the context of disease transformation and relapse.

Greg M. Riedlinger, MD, PhD
Assistant Professor of Pathology
Division of Translational Pathology
Robert Wood Johnson Medical School
Research profile

Dr. Riedlinger’s research interests are in employing next-generation sequencing for molecular oncology, and developing pathology informatics tools for personalized medicine.

Bin Tian, PhD 
Professor of Microbiology, Biochemistry and Molecular Genetics,
New Jersey Medical School,
Rutgers University
Lab website

Dr. Tian’s lab studies RNA biology using molecular systems biology approaches. Currently, we are investigating mechanisms and consequences of alternative cleavage and polyadenylation (APA) in differentiation, development and cancer.

Michael P. Verzi, PhD
Assistant Professor of Genetics
Human Genetics Institute of New Jersey
School of Arts and Sciences
Rutgers University 
Lab website

Dr. Verzi’s lab uses epigenomic approaches to understand how transcriptional regulatory mechanisms contribute to intestinal development and disease, particularly in how tumor suppressor transcription factors interact with tumor chromatin to control progression of colorectal cancer.

William J. Welsh, PhD
Norman H. Edelman Professor in Bioinformatics, Department of Pharmacology,
Robert Wood Johnson Medical School;
Director, Division of Cheminformatics, Biomedical Informatics Program, Rutgers Cancer Institute of New Jersey
Research profile

Dr. Welsh’s lab is interested in drug discovery, chemical informatics, predictive toxicology, medicinal chemistry, rational drug design, pattern recognition, and data mining tools.